Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Metabolic Brain Disease|June 1, 1989
Dopamine and serotonin in rat striatum during in vivo hypoxic-hypoxiaP A Broderick, G E GibsonBiological Psychiatry|June 1, 1988
Serotonergic function in diabetic rats: psychotherapeutic implicationsP A Broderick, J H JacobyDiabetes|July 1, 1988
Diabetes-related changes in L-tryptophan-induced release of striatal biogenic aminesP A Broderick, J H JacobyNeuroscience and Biobehavioral Reviews|May 1, 1997
I. Serotonin (5-HT) within dopamine reward circuits signals open-field behavior. II. Basis for 5-HT--DA interaction in cocaine dysfunctional behaviorP A Broderick, C F PhelixJournal of Neural Transmission (Vienna, Austria : 1996)|November 24, 1998
Clozapine, haloperidol, and the D4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin releaseP A Broderick, M F PierceyProgress in Neuro-Psychopharmacology & Biological Psychiatry|June 3, 1998
Mechanism of triazolo-benzodiazepine and benzodiazepine action in anxiety and depression: behavioral studies with concomitant in vivo CA1 hippocampal norepinephrine and serotonin release detection in the behaving animalP A Broderick, O Hope, P JeannotJournal of Neural Transmission (Vienna, Austria : 1996)|November 1, 2016
Neuromolecular imaging, a nanobiotechnology for Parkinson's disease: advancing pharmacotherapy for personalized medicineP A Broderick, L Wenning, Y-S LiBrain Research|April 20, 2001
Biogenic amines in the human neocortex in patients with neocortical and mesial temporal lobe epilepsy: identification with in situ microvoltammetryS V Pacia, W K Doyle, P A BroderickBehavioural Brain Research|April 1, 1987
A functional separation of behavioral stereotypy based on naloxone-reversible effects of seryl enkephalinamide: comparison with morphineP A Broderick, C D Blaha, R F LaneBrain Research|June 20, 1983
In vivo electrochemical evidence for an enkephalinergic modulation underlying stereotyped behavior: reversibility by naloxoneP A Broderick, C D Blaha, R F LanePageof 5